These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
63 results:

  • 1. Gamma-aminobutyric acid-mediated neuro-immune interactions in glioblastoma: Implications for prognosis and immunotherapy response.
    Sun S; Chen X; Ding N; Zhang M; Li X; Chen L; Sun K; Liu Y
    Life Sci; 2024 Nov; 357():123067. PubMed ID: 39322177
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma.
    Yin B; Cai Y; Chen L; Li Z; Li X
    Int Immunopharmacol; 2024 Nov; 141():112922. PubMed ID: 39137632
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis.
    Barbosa LC; Machado GC; Heringer M; Ferrer VP
    Neurogenetics; 2024 Jul; 25(3):249-262. PubMed ID: 38775886
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. timp1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
    Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Elevated Serum Gastrin Is Associated with Melanoma Progression: Putative Role in Increased Migration and Invasion of Melanoma cells.
    Varga AJ; Nemeth IB; Kemeny L; Varga J; Tiszlavicz L; Kumar D; Dodd S; Simpson AWM; Buknicz T; Beynon R; Simpson D; Krenacs T; Dockray GJ; Varro A
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069171
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.
    Zhong Q; Zhong Q; Cai X; Wu R
    Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma.
    Yang E; Ding Q; Fan X; Ye H; Xuan C; Zhao S; Ji Q; Yu W; Liu Y; Cao J; Fang M; Ding X
    Comput Biol Med; 2023 Aug; 162():107089. PubMed ID: 37267825
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.
    Tang G; Peng J; Huo L; Yin W
    BMC Bioinformatics; 2023 Jun; 24(1):225. PubMed ID: 37264314
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients.
    Yu H; Wang M; Wang X; Jiang X
    FEBS Open Bio; 2023 Feb; 13(2):307-322. PubMed ID: 36560848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas.
    Ahmadi-Beni R; Shahbazi S; Khoshnevisan A
    Diagn Pathol; 2022 Sep; 17(1):73. PubMed ID: 36153549
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High levels of timp1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas.
    Luo CH; Shi Y; Liu YQ; Liu Q; Mao M; Luo M; Yang KD; Wang WY; Chen C; Niu Q; Yan ZX; Miao JY; Zhang XN; Zeng H; Li L; Bian XW; Ping YF
    Lab Invest; 2022 Dec; 102(12):1304-1313. PubMed ID: 35882906
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of FABP7 as a Potential Biomarker for Predicting prognosis and Antiangiogenic Drug Efficacy of Glioma.
    Hou L; Zhou H; Wang Y; Liu J; Zhang D; Li Y; Xue X
    Dis Markers; 2022; 2022():2091791. PubMed ID: 35783014
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of Autophagy-Related Prognostic Signature and Analysis of Immune cell Infiltration in Low-Grade Gliomas.
    Quan Q; Xiong X; Wu S; Yu M
    Biomed Res Int; 2021; 2021():7918693. PubMed ID: 34790823
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive analysis of expression, prognosis and immune infiltration for timps in glioblastoma.
    Han J; Jing Y; Han F; Sun P
    BMC Neurol; 2021 Nov; 21(1):447. PubMed ID: 34781885
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ensemble based machine learning approach for prediction of glioma and multi-grade classification.
    Chandra Joshi R; Mishra R; Gandhi P; Pathak VK; Burget R; Dutta MK
    Comput Biol Med; 2021 Oct; 137():104829. PubMed ID: 34508971
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Overexpression of microRNA-939-5p Contributes to cell Proliferation and Associates Poor prognosis in Glioma.
    Zheng H; Zhao H; Ye G
    Neuromolecular Med; 2021 Dec; 23(4):531-539. PubMed ID: 33786745
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of Brain Low-grade Gliomas Based on Bioinformatics Analysis.
    Xu J; Sun M; Wang Y; Xie A; Gao J
    Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine tumors.
    Jiang S; Zhao L; Xie C; Su H; Yan Y
    Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
    [No Abstract]    [Full Text] [Related]  

  • 20. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
    Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
    Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.